# Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

> **NCT00941369** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 345 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Glargine (HOE901)/NPH Insulin

## Key facts

- **NCT ID:** NCT00941369
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00941369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00941369, "Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00941369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*